Highlights and Quick Summary
- EBITDA Margin for the quarter ending September 29, 2017 was 1.62% (a -128.83% decrease compared to previous quarter)
- Year-over-year quarterly EBITDA Margin decreased by -104.37%
- Annual EBITDA Margin for 2016 was -6.85% (a -439.11% decrease from previous year)
- Annual EBITDA Margin for 2015 was 2.02% (a -58.44% decrease from previous year)
- Twelve month EBITDA Margin ending September 29, 2017 was -10.63% (a -22.69% decrease compared to previous quarter)
- Twelve month trailing EBITDA Margin increased by 55.18% year-over-year
Trailing EBITDA Margin for the last four month:
| 29 Sep '17 | 29 Jun '17 | 30 Mar '17 | 30 Dec '16 |
|---|---|---|---|
| -10.63% | -13.75% | -10.84% | -6.85% |
Visit stockrow.com/AAAP
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical EBITDA Margin of Advanced Accelerator Applications S.A.
Most recent EBITDA Marginof AAAP including historical data for past 10 years.Interactive Chart of EBITDA Margin of Advanced Accelerator Applications S.A.
Advanced Accelerator Applications S.A. EBITDA Margin for the past 10 Years (both Annual and Quarterly)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2017 | – | 1.62% | -5.62% | -8.84% | – |
| 2016 | -37.07% | -6.77% | 8.47% | 7.72% | -6.85% |
| 2015 | – | – | – | 9.23% | 2.02% |
| 2014 | – | – | – | – | 4.86% |
Business Profile of Advanced Accelerator Applications S.A.
Sector: Medical
Industry: Drugs